Literature DB >> 35881335

Preservation of Parasite RNA in the Field.

Bernard Tornyigah1,2, Nicaise Tuikue Ndam3.   

Abstract

The pathogenesis of malaria is largely attributable to the parasite's ability to modulate its cytoadhesion phenotype. This relates to the multigenic families comprising dozens to hundreds of members, whose expression, often mutually exclusive, allows the parasite to vary its adhesive properties and antigenic appearance. This phenomenon is mainly described for the variant surface antigens that the parasite expresses on the infected erythrocyte. In order to decipher these gene expression spectra and identify potential antigenic candidates and/or targets of therapeutic interest, the analysis of the transcriptomes of the parasites directly isolated from patients with well-defined clinical presentation is important. RNA stabilization is an absolute prerequisite for a precise and accurate transcriptome profiling. Immediate stabilization of RNA of biological samples is therefore necessary to prevent degradation by ribonucleases (RNase) or cellular changes. This chapter described methodology for preserving parasite RNA samples from malaria patients in the field for transcriptome studies.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Field isolates; Plasmodium; RNA preservation

Mesh:

Substances:

Year:  2022        PMID: 35881335     DOI: 10.1007/978-1-0716-2189-9_3

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  14 in total

1.  High level of var2csa transcription by Plasmodium falciparum isolated from the placenta.

Authors:  Nicaise G Tuikue Ndam; Ali Salanti; Gwladys Bertin; Madeleine Dahlbäck; Nadine Fievet; Louise Turner; Alioune Gaye; Thor Theander; Philippe Deloron
Journal:  J Infect Dis       Date:  2005-06-14       Impact factor: 5.226

2.  Identification of multiple chondroitin sulfate A (CSA)-binding domains in the var2CSA gene transcribed in CSA-binding parasites.

Authors:  Benoit Gamain; Adama R Trimnell; Christine Scheidig; Artur Scherf; Louis H Miller; Joseph D Smith
Journal:  J Infect Dis       Date:  2005-02-11       Impact factor: 5.226

3.  Identification of a Plasmodium falciparum intercellular adhesion molecule-1 binding domain: a parasite adhesion trait implicated in cerebral malaria.

Authors:  J D Smith; A G Craig; N Kriek; D Hudson-Taylor; S Kyes; T Fagan; T Fagen; R Pinches; D I Baruch; C I Newbold; L H Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

Review 4.  Molecular aspects of severe malaria.

Authors:  Q Chen; M Schlichtherle; M Wahlgren
Journal:  Clin Microbiol Rev       Date:  2000-07       Impact factor: 26.132

Review 5.  Variant surface antigens of Plasmodium falciparum and their roles in severe malaria.

Authors:  Mats Wahlgren; Suchi Goel; Reetesh R Akhouri
Journal:  Nat Rev Microbiol       Date:  2017-06-12       Impact factor: 60.633

6.  Post-Genomic Approaches to Understanding Malaria Parasite Biology: Linking Genes to Biological Functions.

Authors:  Anna E Sexton; Christian Doerig; Darren J Creek; Teresa G Carvalho
Journal:  ACS Infect Dis       Date:  2019-06-20       Impact factor: 5.084

7.  Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering Plasmodium falciparum involved in pregnancy-associated malaria.

Authors:  Ali Salanti; Trine Staalsoe; Thomas Lavstsen; Anja T R Jensen; M P Kordai Sowa; David E Arnot; Lars Hviid; Thor G Theander
Journal:  Mol Microbiol       Date:  2003-07       Impact factor: 3.501

Review 8.  Designing a VAR2CSA-based vaccine to prevent placental malaria.

Authors:  Michal Fried; Patrick E Duffy
Journal:  Vaccine       Date:  2015-11-26       Impact factor: 3.641

Review 9.  Sticking for a Cause: The Falciparum Malaria Parasites Cytoadherence Paradigm.

Authors:  Wenn-Chyau Lee; Bruce Russell; Laurent Rénia
Journal:  Front Immunol       Date:  2019-06-27       Impact factor: 7.561

10.  First-in-human, Randomized, Double-blind Clinical Trial of Differentially Adjuvanted PAMVAC, A Vaccine Candidate to Prevent Pregnancy-associated Malaria.

Authors:  Benjamin Mordmüller; Mihály Sulyok; Diane Egger-Adam; Mafalda Resende; Willem A de Jongh; Mette H Jensen; Helle Holm Smedegaard; Sisse B Ditlev; Max Soegaard; Lars Poulsen; Charlotte Dyring; Carlos Lamsfus Calle; Annette Knoblich; Javier Ibáñez; Meral Esen; Philippe Deloron; Nicaise Ndam; Saadou Issifou; Sophie Houard; Randall F Howard; Steven G Reed; Odile Leroy; Adrian J F Luty; Thor G Theander; Peter G Kremsner; Ali Salanti; Morten A Nielsen
Journal:  Clin Infect Dis       Date:  2019-10-15       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.